Pishas, K.I.; Cowley, K.J.; Pandey, A.; Hoang, T.; Beach, J.A.; Luu, J.; Vary, R.; Smith, L.K.; Shembrey, C.E.; Rashoo, N.;
et al. Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers 2021, 13, 5644.
https://doi.org/10.3390/cancers13225644
AMA Style
Pishas KI, Cowley KJ, Pandey A, Hoang T, Beach JA, Luu J, Vary R, Smith LK, Shembrey CE, Rashoo N,
et al. Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers. 2021; 13(22):5644.
https://doi.org/10.3390/cancers13225644
Chicago/Turabian Style
Pishas, Kathleen I., Karla J. Cowley, Ahwan Pandey, Therese Hoang, Jessica A. Beach, Jennii Luu, Robert Vary, Lorey K. Smith, Carolyn E. Shembrey, Nineveh Rashoo,
and et al. 2021. "Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer" Cancers 13, no. 22: 5644.
https://doi.org/10.3390/cancers13225644
APA Style
Pishas, K. I., Cowley, K. J., Pandey, A., Hoang, T., Beach, J. A., Luu, J., Vary, R., Smith, L. K., Shembrey, C. E., Rashoo, N., White, M. O., Simpson, K. J., Bild, A., Griffiths, J. I., Cheasley, D., Campbell, I., Bowtell, D. D. L., & Christie, E. L.
(2021). Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers, 13(22), 5644.
https://doi.org/10.3390/cancers13225644